PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$36.40
+0.03%Research · Sep 3, 2026
PCRX: FY25 Deep Dive
Pacira BioSciences FY25 at $726M. NI $7M; EPS $0.16.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
Research · Sep 3, 2026
Pacira BioSciences FY25 at $726M. NI $7M; EPS $0.16.